Rep. Duckworth wants to know if the CEO of Mylan crossed the line by working with her mother to require EpiPens in schools?

WASHINGTON, DC - SEPTEMBER 21:  Mylan Inc. CEO Heather Bresch is sworn in during a hearing before the House Oversight and Government Reform Committee September 21, 2016 on Capitol Hill in Washington, DC. The committee held a hearing on "Reviewing the Rising Price of EpiPens."  (Photo by Alex Wong/Getty Images)

WASHINGTON, DC - SEPTEMBER 21: Mylan Inc. CEO Heather Bresch is sworn in during a hearing before the House Oversight and Government Reform Committee September 21, 2016 on Capitol Hill in Washington, DC. The committee held a hearing on "Reviewing the Rising Price of EpiPens." (Photo by Alex Wong/Getty Images)

Senate-seeking U.S. Rep. Tammy Duckworth (D-IL) joins Roe Conn and Anna Davlantes from the halls of Congress to talk about a House Oversight and Government Reform Committee hearing that featured the head of Mylan Inc. – the maker of the EpiPen – Heather Bresch, defending her company’s unprecedented price increase for the life-saving medication. Rep. Duckworth highlights her questions to Ms. Bresch regarding a possible conflict of interest between Bresch’s mother, who is the president of the National Association of State Boards of Education and pushed to require schools to carry Mylan’s EpiPen.

Follow your favorite Roe Conn Show characters on Twitter, we’ll follow back, we promise!

And be sure to follow Roe on Facebook!